Rosetta Comparative Modeling and Ligand Docking for a Transcription Factor Library Design to Select Biosensor for an Anthropogenic Molecule
Abstract not provided.
59 BASIC BIOLOGICAL SCIENCES↗
Engineering topics
Jha, Ramesh Kumar
Publications and source records attributed to Jha, Ramesh Kumar.
Progress of Anaerobic capability at LANL
The anaerobic chamber at LANL is fully functional. The Wolf cell sorter is also functional and easy to use. Clostridium tyrobutyricum strains are growing at anaerobic conditions. Biosensors in Corynebacterium glutamicum have been developed with aerobic reporters. A biosensor for C.tyrobutyricum with Yfast will be developed soon.
59 BASIC BIOLOGICAL SCIENCES↗
Identifying key determinants and dynamics of SARS-CoV-2/ACE2 tight interaction
SARS-CoV-2 virus, the causative agent of Covid-19, has fired up a global pandemic. The virus interacts with the human receptor angiotensin-converting enzyme 2 (ACE2) for an invasion via receptor binding domain (RBD) on its spike protein. To provide a deeper understanding of this interaction, we performed microsecond simulations of the RBD-ACE2 complex for SARS-CoV-2 and compared it with the closely related SARS-CoV discovered in 2003. We show residues in the RBD of SARS-CoV-2 that were mutated from SARS-CoV, collectively help make the RBD anchor much stronger to the N-terminal part of ACE2 than the corresponding residues on RBD of SARS-CoV. This would result in a reduced dissociation rate of SARS-CoV-2 from human receptor protein compared to SARS-CoV. The phenomenon was consistently observed in simulations beyond 500 ns and was reproducible across different force fields. Altogether, our study adds more insight into the critical dynamics of the key residues at the virus spike and human receptor binding interface and potentially aids the development of diagnostics and therapeutics to combat the pandemic efficiently.
60 APPLIED LIFE SCIENCES↗
COVID-19 Testing R&D (Final Report)
Eleven Labs within the US Department of Energy (DOE), National Virtual Biotechnology Laboratory (NVBL), came together as a team to address significant R&D gaps in COVID-19 testing. Beginning in March 2020, the NVBL COVID Testing Team developed an R&D agenda, worked with DOE and other agencies to set priorities, and collaborated to deliver timely results. Priority was given to quick implementation as well as development of novel capabilities for immediate and evolving pandemic needs without placing additional burden on operational performers. Priority elements capitalized on DOE National Laboratory strengths and expertise. The Team delivered: testing and evaluation that enabled decisions on testing options, forwardleaning approaches to prepare for future scale-up needs, and models and experiments that supported prioritization of diagnostic and therapeutic candidates.
60 APPLIED LIFE SCIENCES↗